From: The consequences of implementing non-invasive prenatal testing with cell-free foetal DNA for the detection of Down syndrome in the Spanish National Health Service: a cost-effectiveness analysis
Risk cut-off point
TP
FP
FN
TN
Sensitivity (%)
Specificity (%)
FPR (%)
FNR (%)
1:270
219
2.45
25
53.88
89.75
95.65
4.35
10.25
1:500
225
3.99
19
52.34
92.21
92.91
7.09
7.79
1:1000
230
7.19
14
49.14
94.26
87.23
12.77
5.74